Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2020 Filed Feb 26, 2020 00:09 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
SaleCommon Stock | 12,558 | $4.44 | $55,757.52 |
DisclosureSEC source: 0001209191-20-012763 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874,812 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and awards. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:33 UTC |
Hunkapiller MichaelDirector · Chairman, CEO & President
|
SaleCommon Stock | 525,995 | $4.49 | $2,363,295.54 |
DisclosureSEC source: 0001209191-20-011219 · doc4.xml · nonDerivative · entry 2 Hunkapiller Michael · CIK 0001317102 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Alloy Ventures Disclosed balance after: 2,111,251 F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $4.48 to $4.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F2 · ownership.nature: These are funds affiliated with Alloy Ventures ("Alloy") where the Reporting Person is a General Partner. The Reporting Person disclaims beneficial ownership of any shares held of record by these funds affiliated with Alloy except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:32 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011085 · doc4.xml · nonDerivative · entry 2 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 887,370 F2 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in two (2) equal annual installments on February 18 of each of 2021 and 2022, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:32 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011085 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,370 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in four (4) equal annual installments on February 18 of each of 2021, 2022, 2023, and 2024, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:29 UTC |
Phillips James MichaelSVP, Research & Development
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011070 · doc4.xml · nonDerivative · entry 1 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,030 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the first anniversary of the Grant Date, provided that the Reporting Person continues to serve through the vesting date. Read SEC document |
| March 15, 2019 Filed Apr 10, 2019 20:06 UTC |
Phillips James MichaelSVP, Research & Development
|
GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-024234 · doc4.xml · nonDerivative · entry 1 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,030 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the earlier of (i) the first anniversary of the Grant Date, or (ii) the completion of the proposed acquisition of the Issuer by Illumina, Inc., provided that the Reporting Person continues to serve through the vesting date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 01:47 UTC |
Phillips James MichaelSVP, Research & Development
|
SaleCommon Stock | 7,231 | $7.17 | $51,817.35 |
DisclosureSEC source: 0001209191-19-011851 · doc4.xml · nonDerivative · entry 3 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,530 F3 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and performance awards. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $7.16 to $7.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 01:46 UTC |
ORDONEZ KATHYDirector
|
SaleCommon Stock | 6,933 | $7.17 | $49,695.74 |
DisclosureSEC source: 0001209191-19-011850 · doc4.xml · nonDerivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,767 F2 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and performance awards. F3 · price: This sale price represents the weighted average sale price of the shares sold ranging from $7.16 to $7.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 01:45 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
SaleCommon Stock | 11,987 | $7.16 | $85,850.89 |
DisclosureSEC source: 0001209191-19-011848 · doc4.xml · nonDerivative · entry 3 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,370 F3 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and performance awards. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $7.16 to $7.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 01:44 UTC |
Hunkapiller MichaelDirector · Chairman, CEO & President
|
SaleCommon Stock | 13,335 | $7.19 | $95,825.31 |
DisclosureSEC source: 0001209191-19-011846 · doc4.xml · nonDerivative · entry 3 Hunkapiller Michael · CIK 0001317102 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,398,215 F3 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and performance awards. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $7.16 to $7.21 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:47 UTC |
Phillips James MichaelSVP, Research & Development
|
GrantCommon Stock | 13,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011851 · doc4.xml · nonDerivative · entry 2 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,761 F2 · shares: Represents the number of shares earned upon satisfaction of performance goals in connection with performance-based restricted stock units. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:47 UTC |
Phillips James MichaelSVP, Research & Development
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011851 · doc4.xml · nonDerivative · entry 1 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,156 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the earlier of (i) the first anniversary of the Grant Date, or (ii) the completion of the proposed acquisition of the Issuer by Illumina, Inc., provided that the Reporting Person continues to serve through the vesting date. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:46 UTC |
ORDONEZ KATHYDirector
|
GrantCommon Stock | 19,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011850 · doc4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,700 F1 · shares: Represents the number of shares earned upon satisfaction of performance goals in connection with performance-based restricted stock units. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:45 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
GrantCommon Stock | 19,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011848 · doc4.xml · nonDerivative · entry 2 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749,357 F2 · shares: Represents the number of shares earned upon satisfaction of performance goals in connection with performance-based restricted stock units. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:45 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
GrantCommon Stock | 21,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011848 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729,407 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the earlier of (i) the first anniversary of the Grant Date, or (ii) the completion of the proposed acquisition of the Issuer by Illumina, Inc., provided that the Reporting Person continues to serve through the vesting date. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:44 UTC |
Hunkapiller MichaelDirector · Chairman, CEO & President
|
GrantCommon Stock | 22,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011846 · doc4.xml · nonDerivative · entry 2 Hunkapiller Michael · CIK 0001317102 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,411,550 F2 · shares: Represents the number of shares earned upon satisfaction of performance goals in connection with performance-based restricted stock units. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:44 UTC |
Hunkapiller MichaelDirector · Chairman, CEO & President
|
GrantCommon Stock | 38,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011846 · doc4.xml · nonDerivative · entry 1 Hunkapiller Michael · CIK 0001317102 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,388,750 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the earlier of (i) the first anniversary of the Grant Date, or (ii) the completion of the proposed acquisition of the Issuer by Illumina, Inc., provided that the Reporting Person continues to serve through the vesting date. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,228 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · derivative · entry 6 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,272 Underlying: Common Stock · 18,228 shares Expires 2028-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
Exercise / conversionStock Option (right to buy) · Derivative | 48,762 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · derivative · entry 5 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,762 shares Expires 2023-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option were fully vested and exercisable. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
Exercise / conversionStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · derivative · entry 4 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2022-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option were fully vested and exercisable. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
Exercise / conversionCommon Stock | 18,228 | $2.63 | $47,939.64 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · nonDerivative · entry 3 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 708,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
Exercise / conversionCommon Stock | 48,762 | $2.27 | $110,689.74 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · nonDerivative · entry 2 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
Exercise / conversionCommon Stock | 250,000 | $4.79 | $1,197,500.00 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 21:03 UTC |
ORDONEZ KATHYDirector · Chief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-18-060103 · doc4.xml · derivative · entry 3 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 25,000 shares Expires 2027-11-15 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a four year period. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 21:03 UTC |
ORDONEZ KATHYDirector · Chief Commercial Officer
|
SaleCommon Stock | 25,000 | $7.54 | $188,500.00 |
DisclosureSEC source: 0001209191-18-060103 · doc4.xml · nonDerivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $7.54 to $7.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 21:03 UTC |
ORDONEZ KATHYDirector · Chief Commercial Officer
|
Exercise / conversionCommon Stock | 25,000 | $2.90 | $72,500.00 |
DisclosureSEC source: 0001209191-18-060103 · doc4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2018 Filed Jan 18, 2019 21:05 UTC |
Phillips James MichaelSVP, Research & Development
|
PurchaseCommon Stock | 1 | $2.01 | $2.01 |
DisclosureSEC source: 0001209191-19-004539 · doc5.xml · nonDerivative · entry 2 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,156 F1 · shares: Shares were acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 20:07 UTC |
HENRY CHRISTIAN ODirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001209191-18-044539 · doc4.xml · derivative · entry 1 HENRY CHRISTIAN O · CIK 0001263805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-07-27 F1 · derivative.exercise_date: 1/3 of the shares subject to the option will vest on the one year anniversary of the date of grant, and the balance of shares will vest monthly thereafter over the next two years, provided that the Reporting Person continues to serve as a director through each vesting date. Read SEC document |
| May 22, 2018 Filed May 23, 2018 16:20 UTC |
Shapiro LucyDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001209191-18-032590 · doc4.xml · derivative · entry 1 Shapiro Lucy · CIK 0001435944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:19 UTC |
MOHR MARSHALLDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001209191-18-032589 · doc4.xml · derivative · entry 1 MOHR MARSHALL · CIK 0001252986 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:18 UTC |
MILLIGAN JOHN FDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001209191-18-032585 · doc4.xml · derivative · entry 1 MILLIGAN JOHN F · CIK 0001191589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:18 UTC |
LIVINGSTON RANDALL SDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001209191-18-032584 · doc4.xml · derivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:17 UTC |
Ericson William W.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001209191-18-032583 · doc4.xml · derivative · entry 1 Ericson William W. · CIK 0001503381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:16 UTC |
Botstein DavidDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001209191-18-032579 · doc4.xml · derivative · entry 1 Botstein David · CIK 0001554630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:08 UTC |
ORDONEZ KATHYDirector · Chief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 87,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001209191-18-020144 · doc4.xml · derivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2028-03-15 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:08 UTC |
ORDONEZ KATHYDirector · Chief Commercial Officer
|
GrantCommon Stock | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-020144 · doc4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15 of each of 2019, 2020, 2021, and 2022, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:07 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
GrantStock Option (right to buy) · Derivative | 87,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001209191-18-020140 · doc4.xml · derivative · entry 2 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2028-03-15 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:07 UTC |
BARNES SUSAN KEVP, CFO and PAO
|
GrantCommon Stock | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-020140 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,167 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15 of each of 2019, 2020, 2021, and 2022, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:06 UTC |
Hunkapiller MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001209191-18-020136 · doc4.xml · derivative · entry 2 Hunkapiller Michael · CIK 0001317102 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-03-15 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:06 UTC |
Hunkapiller MichaelDirector · Chairman, CEO & President
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-020136 · doc4.xml · nonDerivative · entry 1 Hunkapiller Michael · CIK 0001317102 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,350,000 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15 of each of 2019, 2020, 2021, and 2022, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| March 01, 2018 Filed Jan 18, 2019 21:05 UTC |
Phillips James MichaelSVP, Research & Development
|
PurchaseCommon Stock | 5,989 | $2.01 | $12,013.93 |
DisclosureSEC source: 0001209191-19-004539 · doc5.xml · nonDerivative · entry 1 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,155 F1 · shares: Shares were acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 22:39 UTC |
Phillips James MichaelSVP, Research & Development
|
GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $2.57 | $0.00 |
DisclosureSEC source: 0001209191-18-011471 · doc4.xml · derivative · entry 2 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-02-15 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 22:39 UTC |
Phillips James MichaelSVP, Research & Development
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011471 · doc4.xml · nonDerivative · entry 1 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,166 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| November 24, 2017 Filed Nov 28, 2017 19:08 UTC |
CORCORAN KEVIN PSVP, Market Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 256 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001209191-17-062664 · doc4.xml · derivative · entry 2 CORCORAN KEVIN P · CIK 0001240009 · SVP, Market Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 256 shares Expires 2017-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option were fully vested and exercisable. Read SEC document |
| November 24, 2017 Filed Nov 28, 2017 19:08 UTC |
CORCORAN KEVIN PSVP, Market Development
|
Exercise / conversionCommon Stock | 256 | $1.96 | $501.76 |
DisclosureSEC source: 0001209191-17-062664 · doc4.xml · nonDerivative · entry 1 CORCORAN KEVIN P · CIK 0001240009 · SVP, Market Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 15, 2017 Filed Nov 15, 2017 21:21 UTC |
ORDONEZ KATHYDirector · Chief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 375,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-060879 · doc4.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2027-11-15 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a four year period. Read SEC document |
| September 01, 2017 Filed Jan 16, 2018 21:01 UTC |
Phillips James MichaelSVP, Research & Development
|
PurchaseCommon Stock | 3,244 | $4.07 | $13,207.95 |
DisclosureSEC source: 0001209191-18-003564 · doc5.xml · nonDerivative · entry 2 Phillips James Michael · CIK 0001504238 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,166 F1 · shares: Shares were acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 20, 2017 Filed Jul 21, 2017 20:12 UTC |
CORCORAN KEVIN PSVP, Market Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 28,061 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001209191-17-045937 · doc4.xml · derivative · entry 2 CORCORAN KEVIN P · CIK 0001240009 · SVP, Market Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256 Underlying: Common Stock · 28,061 shares Expires 2017-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| July 20, 2017 Filed Jul 21, 2017 20:12 UTC |
CORCORAN KEVIN PSVP, Market Development
|
Exercise / conversionCommon Stock | 28,061 | $1.96 | $54,999.56 |
DisclosureSEC source: 0001209191-17-045937 · doc4.xml · nonDerivative · entry 1 CORCORAN KEVIN P · CIK 0001240009 · SVP, Market Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 20:05 UTC |
CORCORAN KEVIN PSVP, Market Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 84,183 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001209191-17-040099 · doc4.xml · derivative · entry 2 CORCORAN KEVIN P · CIK 0001240009 · SVP, Market Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,317 Underlying: Common Stock · 84,183 shares Expires 2017-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.